FF301 股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 截至月份: 2025年12月31日 狀態: 新提交 致：香港交易及結算所有限公司 公司名稱: 卡森國際控股有限公司（於開曼群島註冊成立的有限公司） 呈交日期: 2026年1月2日 I. 法定/註冊股本變動 | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | 於香港聯交所上市 (註1) | | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 00496 | 說明 | 卡森國際控股有限公司 | | | | | | | | | 法定/註冊股份數目 | | 面值 | | | 法定/註冊股本 | | | 上月底結存 | | | 266,666,666,666 USD | | 0.00015 | USD | | 40,000,000 | | 增加 / 減少 (-) | | | | | | USD | | | | 本月底結存 | | | 266,666,666,666 USD | | 0.00015 | USD | ...

Market Overview - The Hong Kong stock market experienced fluctuations and adjustments, with the Hang Seng Index down 0.92% to 25,737.85 points, the Hang Seng Tech Index down 1.79% to 5,537.11 points, the National Enterprises Index down 1.2% to 8,970.29 points, and the Red Chip Index down 0.3% to 4,137.97 points due to the significant drop in US stocks last Friday [1] - Major technology stocks saw declines, with Alibaba down 2.73%, Tencent Holdings down 1.54%, JD Group down 1.12%, Xiaomi down 2.28%, NetEase down 0.18%, Meituan down 1.07%, Kuaishou down 3.85%, and Bilibili down 1.12% [1] - Insurance stocks performed well, with China Ping An reaching a four-year high, while the biopharmaceutical sector weakened, with Baijiazhensheng down over 6% [1] - Semiconductor stocks faced significant declines, with Huahong Semiconductor down over 6% [1] Company News - China Merchants Energy (01138.HK) signed shipbuilding contracts with Dalian China Merchants Heavy Industry, Yangzhou China Merchants Heavy Industry, and Guangdong China Merchants Heavy Industry for the construction of one ethylene ship and eighteen oil tankers, with a total cost of RMB 7.882 billion [2] - ZhongAn Online (06060.HK) reported a cumulative original insurance premium income of approximately RMB 32.904 billion for the first eleven months [3] - R&F Properties (02777.HK) achieved total sales revenue of approximately RMB 12.7 billion in the first eleven months, representing a year-on-year increase of 24.63% [4] - Yida China (03639.HK) reported a contract sales amount of approximately RMB 681 million for the first eleven months, a year-on-year decrease of 23.22% [5] - Kason International (00496.HK) signed a steel structure procurement contract with suppliers, involving an investment of RMB 43.5366 million [5] Clinical and Regulatory Updates - Boke Vision Cloud-B (02592.HK) successfully held a meeting after the second phase of clinical trials for CBT-004 [6] - Fuhong Hanlin (02696.HK) received acceptance from the National Medical Products Administration for the listing registration application of Hanshuo® in combination with chemotherapy for neoadjuvant/adjuvant treatment of gastric cancer, which has been included in priority review [6] - Shijiazhuang Pharmaceutical Group (01093.HK) received approval for a new indication for Donyi® (liposomal irinotecan injection) for first-line treatment in patients with metastatic pancreatic cancer [6] - Hengrui Medicine (01276) received a clinical trial approval notice for HRS-1780 tablets [8] Investment Insights - Guosen Securities indicated that the short-term adjustment in the Hong Kong stock market opens up space for a market rise in 2026, with net inflows from southbound funds exceeding RMB 110 billion in November [13] - Dongwu Securities highlighted that the main focus for Hong Kong stocks is on technology and cyclical sectors, while also paying attention to innovative drugs, suggesting a barbell allocation strategy due to potential macro and political risks [13] - CITIC Securities projected that the Hong Kong stock market will benefit from internal "14th Five-Year Plan" catalysts and external fiscal and monetary easing from major economies, expecting a sustainable upward trend in revenue and profit [13] - Dongwu Securities also forecasted a continued recovery in the Hong Kong stock market in 2026, citing expected interest rate cuts by the Federal Reserve and a temporary easing of Sino-US relations [14]

Market Overview - The Hong Kong stock market opened lower on December 15, with the Hang Seng Index down 1% at 25,718.14 points, the Hang Seng Tech Index down 1.34% at 5,562.67 points, and the State-Owned Enterprises Index down 1.09% at 8,980.13 points [1] - Major tech stocks declined, including Alibaba down 2.14%, Tencent down 1.62%, and JD.com down 0.61% [1] - The innovative drug sector saw several stocks open lower, with Genscript Biotech down 5.92% and Zai Lab down 3.48% [1] - Chinese brokerage stocks collectively fell, with Everbright Securities dropping over 1% [1] - The automotive sector also experienced declines, with Li Auto down over 2% and XPeng down nearly 2% [1] - However, three-child policy concept stocks and photovoltaic stocks mostly rose, with star stock Jinxin Fertility rising about 3% [1] Company News - China Merchants Energy (01138.HK) signed shipbuilding contracts for one ethylene ship and eighteen oil tankers, totaling RMB 7.882 billion [2] - ZhongAn Online (06060.HK) reported cumulative original insurance premium income of approximately RMB 32.904 billion for the first eleven months [3] - R&F Properties (02777.HK) achieved total sales revenue of approximately RMB 12.7 billion in the first eleven months, a year-on-year increase of 24.63% [4] - Yida China (03639.HK) reported contract sales amounting to approximately RMB 681 million in the first eleven months, a year-on-year decrease of 23.22% [5] - Bole Technology (02592.HK) successfully held a meeting after the second phase of clinical trials for CBT-004 [6] - Junshi Biosciences (02696.HK) received acceptance for its marketing application for Hansizhuang® in combination with chemotherapy for gastric cancer [6] - CSPC Pharmaceutical Group (01093.HK) received approval for a new indication for its drug, Donyin® (liposomal irinotecan injection), for first-line treatment in metastatic pancreatic cancer patients [6] - Biyuan (00926.HK) increased its investment in ERX to maintain a 3% stake to support innovative research and development of non-GLP-1 weight loss therapies [7] - Hengrui Medicine (01276) received approval for clinical trials for HRS-1780 tablets [8] - AVIC Industry (02357.HK) plans to acquire a 59.1816% partnership interest in Hangtou Yuhua for a consideration of RMB 202 million [9] - China Environmental Resources (01130.HK) intends to acquire 90% equity in Sichuan Yuanlai Shun Recycling Resources Co., Ltd. for RMB 9 million [10] - AVIC Industry (02357.HK) proposed to implement full circulation of H-shares [11] - Yabo Technology Holdings (08279.HK) signed a framework agreement with Alipay (Hangzhou) [12] Institutional Insights - Guosen Securities indicated that the short-term adjustment in the Hong Kong stock market opens up space for a market rise in 2026, with net inflows from southbound funds exceeding RMB 110 billion in November [13] - CITIC Securities noted strong performance in gold and silver, while other risk assets were weak, predicting a segmented market for precious metals in 2025 [13] - CITIC Securities also emphasized the importance of resource self-sufficiency in the lithium industry, highlighting the need for low-cost quality resources to navigate market cycles [14]

Company News - China COSCO Shipping Energy Transportation Co., Ltd. (中远海能) has signed shipbuilding contracts with Dalian COSCO Shipping Heavy Industry, Yangzhou COSCO Shipping Heavy Industry, and Guangdong COSCO Shipping Heavy Industry for the construction of one ethylene ship and eighteen oil tankers, with a total cost of RMB 7.882 billion [1] - ZhongAn Online P&C Insurance Co., Ltd. (众安在线) reported a total original insurance premium income of approximately RMB 32.904 billion for the first eleven months [2] - R&F Properties Co., Ltd. (富力地产) achieved total sales revenue of approximately RMB 12.7 billion in the first eleven months, representing a year-on-year increase of 24.63% [3] - Yida China Holdings Limited (亿达中国) reported a contracted sales amount of approximately RMB 681 million for the first eleven months, a year-on-year decrease of 23.22% [4] - Karsen International Holdings Limited (卡森国际) has entered into a steel structure procurement contract with suppliers, involving an investment of RMB 43.5366 million [4] Clinical and Regulatory Updates - Bolex Cloud-B (拨康视云-B) successfully held a meeting after the second phase of clinical trials for CBT-004 [5] - Innovent Biologics, Inc. (复宏汉霖) has had its application for the marketing registration of Hansizhuang® combined chemotherapy for gastric cancer accepted by the National Medical Products Administration, and it has been included in the priority review [5] - CSPC Pharmaceutical Group Limited (石药集团) received approval for a new indication for Donyi® (Irinotecan Liposome Injection) for first-line treatment in patients with metastatic pancreatic cancer [5] - Heng Rui Medicine (恒瑞医药) received a clinical trial approval notice for HRS-1780 tablets [7] Investment and Acquisition Activities - AVIC Aviation Industry Corporation (中航科工) plans to acquire a 59.1816% partnership interest in Hangtou Yuhua for a consideration of RMB 202 million [8] - China Environment Resources Holdings Limited (中国环境资源) intends to acquire 90% equity in Sichuan Yuanlai Shun Recycling Resources Co., Ltd. for RMB 9 million [9] - AVIC Aviation Industry Corporation (中航科工) has proposed to implement full circulation of H-shares [10] - Yabo Technology Holdings Limited (亚博科技控股) has entered into a framework agreement with Alipay (Hangzhou) [11] Financing and Buyback Activities - Yum China Holdings, Inc. (百胜中国) has entered into a share buyback agreement with a total repurchase amount of approximately USD 460 million, including about HKD 880 million under the Hong Kong plan, as part of a plan to return USD 1.5 billion to shareholders through dividends and share buybacks by 2026 [12] - Tencent Holdings Limited (腾讯控股) repurchased approximately 1.044 million shares for about HKD 636 million, with repurchase prices ranging from HKD 601.5 to HKD 616 [13] - Xuanwu Cloud (玄武云) repurchased 6,000 shares for a total of HKD 6,467.79, with prices between HKD 1.05 and HKD 1.07 [14] - China COSCO Shipping Holdings Co., Ltd. (中远海控) repurchased approximately 4.461 million shares for about HKD 60.8605 million, with prices ranging from HKD 13.38 to HKD 13.82 [15] - Geely Automobile Holdings Limited (吉利汽车) repurchased approximately 1.362 million shares for about HKD 23.9241 million, with prices between HKD 17.29 and HKD 17.82 [16] - China Anshun Energy (中国安储能源) plans to issue a total of 524 million shares at a discount of approximately 19.12%, aiming to raise about HKD 288.2 million [16]

南财智讯12月12日电，卡森国际（00496.HK）发布须予披露交易公告，卡森国际控股有限公司全资附 属公司卡森国际电力发展有限公司于2025年12月12日与安徽富煌钢构股份有限公司订立合约，同意购买 后者生产的钢结构，包括渮轮机房钢结构、鍅炉运转平台钢结构及汽车存放库钢结构，代价为人民币 4354万元。该款项将分预付款项（5%）、材料准备款项（15%）、交货款项（60%）、安装款项 （15%）及质量保证金（5%）五期以现金支付，预计所有钢结构将于2026年7月31日前交付。本次交易 所涉资金将由本集团内部资源拨付。董事会认为，该合约条款公平合理，符合公司及股东的整体利益。 本次交易旨在支持公司在蒙古巴嘎杭盖建设660兆瓦燃煤发电厂的项目，以拓展能源领域投资，实现收 入来源多元化。 ...

卡森国际(00496)发布公告，于2025年12月12日，买方卡森国际电力发展(本公司的全资附属公司)与供应 商安徽富煌钢构（002743）订立该合约，买方已同意购买及供应商已同意生产并出售钢结构，代价为人 民币4353.66万元。 钢结构是电厂项目不可或缺的结构组件部分。通过对电厂项目的开发与运营，本公司旨在多元化收入来 源并提升长期财务表现。 经考虑"2050年愿景(Vision-2050)"未来数年将为蒙古国内能源投资提供的强有力政策支持;蒙古强劲且持 续增长的电力需求，本公司认为，蒙古发电行业极具吸引力及增长潜力。为此，本公司拟于蒙古巴嘎杭 盖建设及运营一座装机容量为660兆瓦的燃煤发电厂(电厂项目)。本集团已获得蒙古政府的必要批准， 并于2024年7月与蒙古一间国有企业订立购电协议(购电协议)。购电协议已获蒙古能源部长批准。根据 购电协议，本集团有权自商业运营日起向该国有企业供应及销售电厂项目所发电力，期限为25年。 ...

经考虑"2050年愿景(Vision-2050)"未来数年将为蒙古国内能源投资提供的强有力政策支持;蒙古强劲且持 续增长的电力需求，本公司认为，蒙古发电行业极具吸引力及增长潜力。为此，本公司拟于蒙古巴嘎杭 盖建设及运营一座装机容量为660兆瓦的燃煤发电厂(电厂项目)。本集团已获得蒙古政府的必要批准， 并于2024年7月与蒙古一间国有企业订立购电协议(购电协议)。购电协议已获蒙古能源部长批准。根据 购电协议，本集团有权自商业运营日起向该国有企业供应及销售电厂项目所发电力，期限为25年。 钢结构是电厂项目不可或缺的结构组件部分。通过对电厂项目的开发与运营，本公司旨在多元化收入来 源并提升长期财务表现。 智通财经APP讯，卡森国际(00496)发布公告，于2025年12月12日，买方卡森国际电力发展(本公司的全 资附属公司)与供应商安徽富煌钢构订立该合约，买方已同意购买及供应商已同意生产并出售钢结构， 代价为人民币4353.66万元。 ...

格隆汇12月12日丨卡森国际(00496.HK)宣布，于2025年12月12日，买方(公司全资附属公司)与供应商订 立该合约，据此，买方已同意购买及供应商已同意生产并出售钢结构，代价为人民币4353.66万元。 ...

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不 負責，對其準確性或完整性亦不發表任何聲明，並明確表示，概不對因本公告 全部或任何部分內容而產生或因倚賴該等內容而引致的任何損失承擔任何責 任。 KASEN INTERNATIONAL HOLDINGS LIMITED 董事會欣然宣佈，於二零二五年十二月十二日（交易時段後），買方（本公司之 全資附屬公司）與供應商訂立該合約，據此，買方已同意購買及供應商已同意 生產並出售鋼結構，代價為人民幣43,536,600元。 上市規則之涵義 於本公告日期，由於該合約項下交易之一項或多項適用百分比率（定義見上市 規則第14.07條）超過5%但均低於25%，故訂立該合約構成上市規則第14章項 下本公司之須予披露交易，並須遵守上市規則項下之申報及公告規定。 緒言 董事會欣然宣佈，於二零二五年十二月十二日（交易時段後），買方（本公司之全 資附屬公司）與供應商訂立該合約，據此，買方已同意購買及供應商已同意生產 並出售鋼結構，代價為人民幣43,536,600元。 1 該合約 卡森國際控股有限公 司 （於開曼群島註冊成立的受豁免有限公司） （股份代號：496） 有關鋼結 ...

股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 截至月份: 2025年11月30日 狀態: 新提交 致：香港交易及結算所有限公司 公司名稱: 卡森國際控股有限公司（於開曼群島註冊成立的有限公司） 呈交日期: 2025年12月1日 I. 法定/註冊股本變動 | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | 於香港聯交所上市 (註1) | | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 00496 | 說明 | 卡森國際控股有限公司 | | | | | | | | | 法定/註冊股份數目 | | 面值 | | | 法定/註冊股本 | | | 上月底結存 | | | 266,666,666,666 USD | | 0.00015 | USD | | 40,000,000 | | 增加 / 減少 (-) | | | | | | USD | | | | 本月底結存 | | | 266,666,666,666 USD | | 0.00015 | USD | | 40 ...